Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spindle Cell Neoplasm”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Looking for participantsNCT02734537
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+13 more
ECOG-ACRIN Cancer Research Group 189
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT02567435
What this trial is testing

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Who this might be right for
Alveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+3 more
National Cancer Institute (NCI) 325
Not applicableAvailableNCT05974410
What this trial is testing

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Who this might be right for
GlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more
AVM Biotechnology Inc
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Not applicableLooking for participantsNCT07675967
What this trial is testing

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Who this might be right for
Lung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more
Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Ended earlyNCT02022358
What this trial is testing

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

Who this might be right for
OsteosarcomaSpindle Cell Sarcoma of Bone
University College, London 34
Early research (Phase 1)Active Not RecruitingNCT04420975
What this trial is testing

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more
Jonsson Comprehensive Cancer Center 14
Large-scale testing (Phase 3)Looking for participantsNCT05304585
What this trial is testing

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Who this might be right for
Embryonal RhabdomyosarcomaFusion-Negative Alveolar RhabdomyosarcomaSpindle Cell/Sclerosing Rhabdomyosarcoma
Children's Oncology Group 205
Large-scale testing (Phase 3)Active Not RecruitingNCT04994132
What this trial is testing

Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Who this might be right for
Alveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+5 more
Children's Oncology Group 113
Not applicableStudy completedNCT02986503
What this trial is testing

European Study in Bone Sarcoma Patients Over 40 Years

Who this might be right for
Spindle Cell Sarcoma of BoneOsteosarcoma
Italian Sarcoma Group 100
Testing effectiveness (Phase 2)Study completedNCT03719430
What this trial is testing

APX005M and Doxorubicin in Advanced Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Alexander Z. Wei, MD 27
Testing effectiveness (Phase 2)Study completedNCT01962103
What this trial is testing

Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more
Celgene 107
Testing effectiveness (Phase 2)WithdrawnNCT05116800
What this trial is testing

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Who this might be right for
Soft Tissue SarcomaUndifferentiated Pleomorphic SarcomaMyxofibrosarcoma+10 more
Brown University
Not applicableNot Yet RecruitingNCT06550765
What this trial is testing

Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors

Who this might be right for
Sarcoma, Soft TissueSarcoma, Spindle Cell
Guangdong Provincial People's Hospital 98
Testing effectiveness (Phase 2)Study completedNCT00821249
What this trial is testing

ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Pfizer 55
Early research (Phase 1)Study completedNCT01248923
What this trial is testing

ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Array Biopharma, now a wholly owned subsidiary of Pfizer 55
Not applicableLooking for participantsNCT04300257
What this trial is testing

Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

Who this might be right for
Sarcoma
Kantonsspital Winterthur KSW 600
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
St. Jude Children's Research Hospital 139
Large-scale testing (Phase 3)Temporarily pausedNCT06568172
What this trial is testing

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Who this might be right for
Eyelid Squamous Cell CarcinomaRecurrent Eyelid Squamous Cell CarcinomaRecurrent Skin Acantholytic Squamous Cell Carcinoma+17 more
National Cancer Institute (NCI) 420
Next Page